Viewing Study NCT00136292


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-01-24 @ 5:01 PM
Study NCT ID: NCT00136292
Status: COMPLETED
Last Update Posted: 2020-03-11
First Post: 2005-08-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gram-positive Bacterial Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gram-Positive Infection View